Publication | Closed Access

Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants

Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyMethotrexate ToxicityConsolidation PhasePharmacotherapyPharmacogenetic DeterminantsPharmacologyCancer ResearchMyeloid Neoplasia